Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: RANDOMISED trial

Clinical Nutrition

Volumn 33, Issue 6, 2014, Pages 1017-1023

  Sánchez Lara, Karla ^a   Turcott, Jenny G ^a   Juárez Hernández, Eva ^a   Nuñez Valencia, Carolina ^a   Villanueva, Geraldine ^a   Guevara, Patricia ^b   De la Torre Vallejo, Martha ^a   Mohar, Alejandro ^a   Arrieta, Oscar ^a,c  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Eicosapentaenoic acid; Health related quality of life; Non small cell lung cancer; Nutritional status

Indexed keywords

C REACTIVE PROTEIN; CARBOPLATIN; CISPLATIN; ICOSAPENTAENOIC ACID; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CALORIC INTAKE; CANCER SURVIVAL; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY COMPLIANCE; FAT INTAKE; FAT MASS; FATIGUE; FEMALE; HUMAN; LEAN BODY WEIGHT; LOSS OF APPETITE; MALE; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VERY ELDERLY; ADOLESCENT; APPETITE; BODY COMPOSITION; BODY WEIGHT; CARCINOMA, NON-SMALL-CELL LUNG; DRUG EFFECTS; INTERVENTION STUDY; MIDDLE AGED; NUTRITIONAL STATUS; ORAL DRUG ADMINISTRATION; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APPETITE; BODY COMPOSITION; BODY WEIGHT; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; ENERGY INTAKE; FEMALE; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROGNOSIS; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84920145764     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.03.006     Document Type: Article

References (30)

1. Scagliotti G.V., De Marinis F., Rinaldi M., Crinò L., Gridelli C., Ricci S., et al. Italian Lung Cancer Project l: phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. JClin Oncol 2002, 20:4285-4291.
2. Argiles J.M., Olivan M., Busquets S., López-Soriano F. Optimal management of cancer anorexia-cachexia syndrome. Cancer Manag Res 2010, 2:27-38.
3. Fearon K.C., Barber M.D., Moses A.G. The cancer cachexia syndrome. Surg Oncol Clin N Am 2001, 10:109-126.
4. Laviano A., Seelaender M., Sanchez-Lara K., Gioulbasanis I., Molfino A., Rossi Fanelli F. Beyond anorexia -cachexia. Nutrition and modulation of cancer patients' metabolism: supplementary, complementary or alternative anti-neoplastic therapy?. Eur J Pharmacol 2011, 668(Suppl.1):S87-S90.
5. Arrieta O., Michel Ortega R.M., Villanueva-Rodríguez G., Serna-Thomé M.G., Flores-Estrada D., Diaz-Romero C., et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 2010, 10:50.
6. Sánchez-Lara K., Turcott J.G., Juárez E., Guevara P., Núñez-Valencia C., Oñate-Ocaña L.F., et al. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer 2012, 64:526-534.
7. Baldwin C., Spiro A., Ahern R., Emery P.W. Oral nutritional interventions in malnourished patients with Cancer: a systematic review and Meta-analysis. JNatl Cancer Inst 2012, 104:371-385.
8. Ramos E.J., Middleton F.A., Laviano A., Sato T., Romanova I., Das U.N., et al. Effects of omega-3 fatty acid supplementation on tumor-bearing rats. JAm Coll Surg 2004, 199:716-723.
9. Barber M.D., Ross J.A., Fearon K.C. The anti-cachectic effect of fatty acids. Proc Nutr Soc 1998, 57:571-576.
10. Jordan A., Stein J. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2. Eur J Nutr 2003, 42:324-331.
11. Baracos V.E., Mazurak V.C., Ma D.W. n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexia. Nutr Res Rev 2004, 17:177-192.
12. Hernández-Avila M., Romieu I., Parra S., Hernández-Avila J., Madrigal H., Willett W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Sal Pub Mex 1998, 40:133-140.
13. Yamanaka T., Matsumoto S., Teramukai S., Ishiwata R., Nagai Y., Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007, 73:215-220.
14. Rodríguez-Reyna T.S., Arrieta O., Castillo-Martínez L., Orea-Tejeda A., Guevara P., Rebollar V., et al. Tumour Necrosis Factorα and Troponin T as predictors of poor prognosis in patients with stable heart failure. Clin Invest Med 2005, 28:24-29.
15. Arrieta Ó., Núñez-Valencia C., Reynoso-Erazo L., Alvarado S., Flores-Estrada D., Angulo L.P., et al. Health-related quality of life in patients with lung cancer: Validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire. Lung Cancer 2012, 77:205-211.
16. Tisdale M.J. Mechanisms of cancer cachexia. Physiol Rev 2009, 89:381-410.
17. van der Meij B.S., Langius J.A., Spreeuwenberg M.D., Slootmaker S.M., Paul M.A., Smit E.F., et al. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur J Clin Nutr 2012, 66:399-404.
18. Finocchiaro C., Segre O., Fadda M., Monge T., Scigliano M., Schena M., et al. Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. Br J Nutr 2012, 108:327-333.
19. van der Meij B.S., Langius J.A., Smit E.F., Spreeuwenberg M.D., von Blomberg B.M., Heijboer A.C., et al. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. JNutr 2010, 140:1774-1780.
20. Santarpia L., Contaldo F., Pasanisi F. Nutritional screening and early treatment of malnutrition in cancer patients. JCachexia Sarcopenia Muscle 2011, 2:27-35.
21. Arrieta Ó., Hernández-Pedro N., Fernández-González-Aragón M.C., Saavedra-Pérez D., Campos-Parra A.D., Ríos-Trejo M.Á., et al. Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer. Neurology 2011, 77:987-995.
22. Arrieta O., García-Navarrete R., Zúñiga S., Ordóñez G., Ortiz A., Palencia G., et al. Retinoic acid increases tissue and plasma contents of nerve growth factor and prevents neuropathy in diabetic mice. Eur J Clin Invest 2005, 35:201-207.
23. Fearon K.C., Barber M.D., Moses A.G., Ahmedzai S.H., Taylor G.S., Tisdale M.J., et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. JClin Oncol 2006, 24:3401-3407.
24. Fearon K.C., Von Meyenfeldt M.F., Moses A.G., Van Geenen R., Roy A., Gouma D.J., et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003, 52:1479-1486.
25. Tan B.H., Birdsell L.A., Martin L., Baracos V.E., Fearon K.C. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009, 15:6973-6979.
26. Murphy R.A., Mourtzakis M., Chu Q., Baracos V.E., Reiman T., Mazurak V.C. Nutritional intervention with fish oil provides benefit over standard of care for weight and skeletal muscle mass in patients wirh nonsmall cell lung cancer receiving chemotherapy. Cancer 2011, 1117:1775-1782.
27. Barber M.D., Fearon K.C., Tisdale M.J., McMillan D.C., Ross J.A. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 2001, 40:118-124.
28. Jho D.H., Babcock T.A., Tevar R., Helton W.S., Espat N.J. Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy. JParenter Enteral Nutr 2002, 26:291-297.
29. Colas S., Mahéo K., Denis F., Goupille C., Hoinard C., Champeroux P., et al. Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization. Clin Cancer Res 2006, 12:5879-5886.
30. Murphy R.A., Mourtzakis M., Chu Q., Baracos V.E., Reiman T., Mazurak V.C. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 2011, 3774-3780.